A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?

Editorial

Dimitrios T Boumpas et al. Ann Rheum Dis. 2010 Dec.

. 2010 Dec;69(12):2059-61.

doi: 10.1136/ard.2010.139683.

No abstract available

Comment on

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R; MAINTAIN Nephritis Trial Group. Houssiau FA, et al. Ann Rheum Dis. 2010 Dec;69(12):2083-9. doi: 10.1136/ard.2010.131995. Epub 2010 Sep 10. Ann Rheum Dis. 2010. PMID: 20833738 Free PMC article. Clinical Trial.

1. Boumpas DT, Austin HA, 3rd, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 1992;340:741–5. - PubMed
1. Austin HA, 3rd, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986;314:614–19. - PubMed
1. Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008;67:195–205. - PubMed
1. Boumpas DT, Austin HA, 3rd, Vaughan EM, et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med. 1993;119:366–9. - PubMed
1. Cravedi P, Perna A, Ruggenenti P, et al. Mycophenolate mofetil versus azathioprine in organ transplantation. Am J Transplant. 2009;9:2856–7. - PubMed